Mettler-Toledo International Inc. (NYSE:MTD) Stock Position Lowered by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co lessened its position in Mettler-Toledo International Inc. (NYSE:MTD) by 8.2% in the 1st quarter, Holdings Channel reports. The fund owned 20,559 shares of the medical instruments supplier’s stock after selling 1,830 shares during the period. CANADA LIFE ASSURANCE Co’s holdings in Mettler-Toledo International were worth $27,401,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in MTD. CVA Family Office LLC purchased a new stake in Mettler-Toledo International in the 4th quarter worth approximately $27,000. Raymond James Financial Services Advisors Inc. raised its holdings in shares of Mettler-Toledo International by 25.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 1,676 shares of the medical instruments supplier’s stock valued at $2,033,000 after purchasing an additional 340 shares in the last quarter. Values First Advisors Inc. raised its holdings in shares of Mettler-Toledo International by 2.6% during the 4th quarter. Values First Advisors Inc. now owns 1,139 shares of the medical instruments supplier’s stock valued at $1,382,000 after purchasing an additional 29 shares in the last quarter. Caprock Group LLC raised its holdings in shares of Mettler-Toledo International by 450.2% during the 4th quarter. Caprock Group LLC now owns 1,733 shares of the medical instruments supplier’s stock valued at $2,102,000 after purchasing an additional 1,418 shares in the last quarter. Finally, Patron Partners LLC raised its holdings in shares of Mettler-Toledo International by 1.3% during the 4th quarter. Patron Partners LLC now owns 1,368 shares of the medical instruments supplier’s stock valued at $1,659,000 after purchasing an additional 18 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,410.25 on Friday. The firm has a market capitalization of $30.12 billion, a price-to-earnings ratio of 39.55, a P/E/G ratio of 3.71 and a beta of 1.17. The company’s fifty day moving average is $1,416.86 and its two-hundred day moving average is $1,313.96. Mettler-Toledo International Inc. has a 52-week low of $928.49 and a 52-week high of $1,535.86.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.61 by $1.28. The company had revenue of $925.95 million for the quarter, compared to analyst estimates of $879.72 million. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. The business’s quarterly revenue was down .3% on a year-over-year basis. During the same period last year, the business posted $8.69 EPS. As a group, sell-side analysts expect that Mettler-Toledo International Inc. will post 40.13 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Thomas P. Salice sold 1,268 shares of Mettler-Toledo International stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the sale, the director now directly owns 244 shares in the company, valued at approximately $363,603.92. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, insider Christian Magloth sold 1,100 shares of Mettler-Toledo International stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,470.97, for a total transaction of $1,618,067.00. Following the sale, the insider now directly owns 734 shares in the company, valued at approximately $1,079,691.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Thomas P. Salice sold 1,268 shares of Mettler-Toledo International stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the sale, the director now owns 244 shares in the company, valued at $363,603.92. The disclosure for this sale can be found here. Insiders have sold 3,278 shares of company stock worth $4,871,849 in the last ninety days. Insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

MTD has been the topic of a number of recent research reports. Robert W. Baird raised their price target on shares of Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the company a “neutral” rating in a report on Monday, May 13th. Jefferies Financial Group restated an “underperform” rating and set a $1,250.00 price target (up previously from $1,230.00) on shares of Mettler-Toledo International in a report on Monday, June 3rd. The Goldman Sachs Group raised their price target on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a “neutral” rating in a report on Tuesday, July 9th. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Thursday, July 11th. Finally, Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the company an “in-line” rating in a research note on Tuesday, July 2nd. Two research analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $1,301.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.